Breakthrough discovery to transform prostate cancer treatment
(University of South Australia) A novel formulation of the prostate cancer drug abiraterone acetate - currently marketed as Zytiga - will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University of South Australia show the new formulation improves the drug's effectiveness by 40 per cent.
Source: EurekAlert! - Biology - Category: Biology Source Type: news
More News: Abiraterone Acetate | Australia Health | Biology | Cancer | Cancer & Oncology | Clinical Trials | Prostate Cancer